Tianjin Ringpu Bio-Technology Co.,Ltd. Share Price

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 03/09/2026 5-day change 1st Jan Change
17.26 CNY -3.25% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +0.35% -8.04%

Valuation : Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.84B 1.17B 1B 942M 862M 1.61B 110B 1.62B 11.14B 4.34B 56.34B 4.38B 4.28B 181B P/E 2026 *
18.7x
P/E 2027 * 15.9x
Enterprise Value 8.34B 1.24B 1.07B 1B 917M 1.71B 117B 1.72B 11.85B 4.62B 59.96B 4.66B 4.56B 193B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.94x
Free-Float
51.96%
Yield 2026 *
1.74%
Yield 2027 * 2.78%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
29/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
13/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day-3.25%
1 week+0.35%
Current month-0.23%
1 month+0.23%
3 months+7.88%
6 months-7.75%
Current year-8.04%
1 week 17.13
Extreme 17.13
18.05
1 month 16.59
Extreme 16.59
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.96
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 29/03/2023
Director of Finance/CFO 51 27/04/2022
Corporate Officer/Principal 45 26/10/2020
Director TitleAgeSince
Chairman 63 11/05/2008
Director/Board Member 53 24/12/2019
Director/Board Member 51 09/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-3.25%+0.35%-18.89%-9.25% 1.17B
+0.16%+1.69%-49.95%-60.37% 31.52B
-1.05%-0.29%+40.75%+97.09% 12.2B
-0.48%-3.48%-14.75%+2.97% 3.81B
-0.62%-1.39%-2.15%+18.37% 3.13B
+0.08%-3.30%+50.80%+30.51% 2B
+0.07%-3.08%+14.27%+6.00% 1.92B
-3.36%+6.13%+1.01%+165.89% 1.57B
-0.30%-0.74%-9.42%-42.18% 1.02B
-0.72%-1.14%-7.47%-21.32% 944M
Average -0.95%-0.79%+0.42%+18.77% 5.93B
Weighted average by Cap. -0.36%+0.36%-17.69%-6.61%

Financials

2026 *2027 *
Net sales 3.73B 556M 478M 449M 410M 766M 52.53B 772M 5.31B 2.07B 26.84B 2.09B 2.04B 86.45B 4.21B 626M 539M 505M 462M 863M 59.18B 870M 5.98B 2.33B 30.24B 2.35B 2.3B 97.41B
Net income 428M 63.72M 54.83M 51.45M 47.07M 87.86M 6.02B 88.55M 609M 237M 3.08B 239M 234M 9.91B 504M 75.02M 64.55M 60.57M 55.42M 103M 7.09B 104M 717M 279M 3.62B 282M 276M 11.67B
Net Debt 503M 74.8M 64.36M 60.39M 55.26M 103M 7.07B 104M 714M 278M 3.61B 281M 275M 11.64B 339M 50.42M 43.38M 40.71M 37.24M 69.51M 4.77B 70.06M 482M 188M 2.44B 189M 185M 7.84B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
03/09/26 CN¥17.26 -3.25% 4,850,800
02/09/26 CN¥17.84 +1.77% 6,666,976
01/09/26 CN¥17.53 +1.33% 5,671,777
31/08/26 CN¥17.30 0.00% 5,255,897
28/08/26 CN¥17.30 +0.58% 4,256,797
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.26CNY
Average target price
20.41CNY
Spread / Average Target
+18.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock